Schoretsanitis, Georgios http://orcid.org/0000-0002-3851-4117
Augustin, Marc
Saßmannshausen, Helena
Franz, Cordula
Gründer, Gerhard
Paulzen, Michael
Article History
Received: 2 March 2018
Accepted: 10 August 2018
First Online: 16 August 2018
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained by all patients participating in this study.
: Gerhard Gründer has served as a consultant for Boehringer Ingelheim (Ingelheim, Germany), Cheplapharm (Greifswald, Germany), Eli Lilly (Indianapolis, Ind, USA), Lundbeck (Copenhagen, Denmark), Ono Pharmaceuticals (Osaka, Japan), Roche (Basel, Switzerland), Servier (Paris, France), and Takeda (Osaka, Japan). He has served on the speakers’ bureau of Eli Lilly, Gedeon Richter (Budapest, Hungary), Janssen Cilag (Neuss, Germany), Lundbeck, Roche, Servier, and Trommsdorf (Aachen, Germany). He has received grant support from Boehringer Ingelheim and Roche. He is co-founder of Pharma Image GmbH (Düsseldorf, Germany) and Brainfoods UG (Selfkant, Germany). Georgios Schoretsanitis received a grant from the bequest “in memory of Maria Zaoussi,” State Scholarships Foundation, Greece, for clinical research in Psychiatry for the academic year 2015–2016. The authors declare that they have no conflict of interest.